Research map: Reply

Back to the article

Papers in this map

  1. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis · David T. Felson · 1995 · 2850 citations · Cited by this paper
  2. The Role of IgM Anti‐acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis · 2026 · Related
  3. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 · Philip J. Mease · 2016 · 586 citations · Cited by this paper
  4. Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis · 2026 · Related
  5. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial · Peter T. Nash · 2017 · 413 citations · Cited by this paper
  6. Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression · 2026 · Related
  7. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis · Lihi Eder · 2014 · 215 citations · Cited by this paper
  8. Dermatomyositis in skin of color population: expanding clinical recognition · 2026 · Related
  9. Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis · Matteo Nicola Dario Di Minno · 2012 · 190 citations · Cited by this paper
  10. Age‐associated B cells contribute to inflammation via antibody‐independent mechanisms in Takayasu's arteritis · 2026 · Related
  11. The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries · Pil Højgaard · 2016 · 147 citations · Cited by this paper
  12. Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial · 2026 · Related
  13. Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial · Joseph Frank Merola · 2026 · 26 citations · Cited by this paper
  14. Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real‐world data from the ILD ‐ PRO Registry · 2026 · Related
  15. Cytokine‐induced NRP2 expression in rheumatoid arthritis fibroblast‐like synoviocytes: comment on the article by Jin et al · 2026 · Related
  16. Human Fibroblast–Myeloid Cell Tissue Atlas Across the Lungs, Synovium, Skin, and Heart · 2026 · Related
  17. BCMA ‐ CD19 CAR T Cells in Systemic Lupus Erythematosus: Humoral Reset or Antigen‐Specific Tolerance? · 2026 · Related

Source: OpenAlex (CC0)